Works matching IS 13479032 AND DT 2024 AND VI 115 AND IP 3

Results: 29

In this issue: Volume 115, Issue 3, March 2024.

Published in:: Cancer Science, 2024, v. 115, n. 3, p. 695, doi. 10.1111/cas.16115
Publication type:: Article

Progressive, multi‐organ, and multi‐layered nature of cancer cachexia.

Published in:

Cancer Science, 2024, v. 115, n. 3, p. 715, doi. 10.1111/cas.16078

By:

Nakamura, Yuki;
Saldajeno, Don Pietro;
Kawaguchi, Kosuke;
Kawaoka, Shinpei

Publication type:

Article

Role of catecholamine synthases in the maintenance of cancer stem‐like cells in malignant peripheral nerve sheath tumors.

Published in:

Cancer Science, 2024, v. 115, n. 3, p. 871, doi. 10.1111/cas.16077

By:

Katayama, Haruyoshi;
Fujimura, Atsushi;
Huang, Rongsheng;
Otani, Yusuke;
Itano, Takuto;
Fujiwara, Tomohiro;
Kunisada, Toshiyuki;
Nakata, Eiji;
Ozaki, Toshifumi

Publication type:

Article

DEAD‐box helicase 1 inhibited CD8+ T cell antitumor activity by inducing PD‐L1 expression in hepatocellular carcinoma.

Published in:

Cancer Science, 2024, v. 115, n. 3, p. 763, doi. 10.1111/cas.16076

By:

Liu, Junhao;
Yang, Ti;
Luo, Yurong;
Ma, Zengxin;
Yu, Zhitao;
Zhang, Lei;
Liu, Gai;
Wen, Jianfan;
Lu, Guankun;
Zhang, Guowei;
Zhao, Yujun;
Luo, Wang;
Li, Yanan;
Yang, Nengjia;
Zhou, Jiawei;
Lu, Yuhui;
Chen, Siliang;
Zeng, Xiancheng

Publication type:

Article

Stiffness promotes cell migration, invasion, and invadopodia in nasopharyngeal carcinoma by regulating the WT‐CTTN level.

Published in:

Cancer Science, 2024, v. 115, n. 3, p. 836, doi. 10.1111/cas.16075

By:

Bao, Lili;
Zhong, Ming;
Zhang, Zixiang;
Yu, Xiangqing;
You, Bo;
You, Yiwen;
Gu, Miao;
Zhang, Qicheng;
Chen, Wenhui;
Lei, Wei;
Hu, Songqun

Publication type:

Article

Altered tumor signature and T‐cell profile after chemotherapy reveal new therapeutic opportunities in high‐grade serous ovarian carcinoma.

Published in:

Cancer Science, 2024, v. 115, n. 3, p. 989, doi. 10.1111/cas.16074

By:

Kang, Huiram;
Hwang, Sohyun;
Kang, Haeyoun;
Jo, Areum;
Lee, Ji Min;
Choi, Jung Kyoon;
An, Hee Jung;
Lee, Hae‐Ock

Publication type:

Article

Interleukin‐4 induced 1‐mediated resistance to an immune checkpoint inhibitor through suppression of CD8+ T cell infiltration in melanoma.

Published in:

Cancer Science, 2024, v. 115, n. 3, p. 791, doi. 10.1111/cas.16073

By:

Hirose, Shiho;
Mashima, Tetsuo;
Yuan, Xunmei;
Yamashita, Makiko;
Kitano, Shigehisa;
Torii, Shinichi;
Migita, Toshiro;
Seimiya, Hiroyuki

Publication type:

Article

Why Y matters? The implication of loss of Y chromosome in blood and cancer.

Published in:

Cancer Science, 2024, v. 115, n. 3, p. 706, doi. 10.1111/cas.16072

By:

Wang, Ying;
Sano, Soichi

Publication type:

Article

Genome‐wide loss‐of‐function genetic screen identifies INSIG2 as the vulnerability of hepatitis B virus‐integrated hepatoma cells.

Published in:

Cancer Science, 2024, v. 115, n. 3, p. 859, doi. 10.1111/cas.16070

By:

Fukuoka, Makoto;
Kodama, Takahiro;
Murai, Kazuhiro;
Hikita, Hayato;
Sometani, Emi;
Sung, Jihyun;
Shimoda, Akiyoshi;
Shigeno, Satoshi;
Motooka, Daisuke;
Nishio, Akira;
Furuta, Kunimaro;
Tatsumi, Tomohide;
Yusa, Kosuke;
Takehara, Tetsuo

Publication type:

Article

Enhancer‐activated RET confers protection against oxidative stress to KMT2A‐rearranged acute myeloid leukemia.

Published in:

Cancer Science, 2024, v. 115, n. 3, p. 963, doi. 10.1111/cas.16069

By:

Frett, Brendan;
Stephens, Kimberly E.;
Koss, Brian;
Melnyk, Stepan;
Farrar, Jason;
Saha, Debasmita;
Roy Choudhury, Samrat

Publication type:

Article

IRG1 restrains M2 macrophage polarization and suppresses intrahepatic cholangiocarcinoma progression via the CCL18/STAT3 pathway.

Published in:

Cancer Science, 2024, v. 115, n. 3, p. 777, doi. 10.1111/cas.16068

By:

Zhou, Menghua;
Yu, Hongjun;
Bai, Miaoyu;
Lu, Shounan;
Wang, Chaoqun;
Ke, Shanjia;
Huang, Jingjing;
Li, Zihao;
Xu, Yanan;
Yin, Bing;
Li, Xinglong;
Feng, Zhigang;
Fu, Yao;
Jiang, Hongchi;
Ma, Yong

Publication type:

Article

Circular RNA circWNK1 inhibits the progression of gastric cancer via regulating the miR‐21‐3p/SMAD7 axis.

Published in:

Cancer Science, 2024, v. 115, n. 3, p. 974, doi. 10.1111/cas.16067

By:

Dai, Ting;
Qiu, Shengkui;
Gao, Xuesong;
Zhao, Chengjin;
Ge, Zhenming;
Yang, Yanmei;
Tang, Chong;
Feng, Shichun

Publication type:

Article

Ex vivo expansion of human hematopoietic stem cells and clinical applications.

Published in:

Cancer Science, 2024, v. 115, n. 3, p. 698, doi. 10.1111/cas.16066

By:

Sakurai, Masatoshi;
Ishitsuka, Kantaro;
Becker, Hans Jiro;
Yamazaki, Satoshi

Publication type:

Article

Patient survey on cancer genomic medicine in Japan under the national health insurance system.

Published in:

Cancer Science, 2024, v. 115, n. 3, p. 954, doi. 10.1111/cas.16065

By:

Kage, Hidenori;
Akiyama, Nana;
Chang, Hyangri;
Shinozaki‐Ushiku, Aya;
Ka, Mirei;
Kawata, Junichi;
Muto, Manabu;
Okuma, Yusuke;
Okita, Natsuko;
Tsuchihara, Katsuya;
Kikuchi, Junko;
Shirota, Hidekazu;
Hayashi, Hideyuki;
Kokuryo, Toshio;
Yachida, Shinichi;
Hirasawa, Akira;
Kubo, Makoto;
Kenmotsu, Hirotsugu;
Tanabe, Masahiko;
Ushiku, Tetsuo

Publication type:

Article

Anti‐angiogenesis in colorectal cancer therapy.

Published in:

Cancer Science, 2024, v. 115, n. 3, p. 734, doi. 10.1111/cas.16063

By:

Yang, Zhenni;
Zhang, Xuqian;
Bai, Xiaozhe;
Xi, Xiaonan;
Liu, Wentian;
Zhong, Weilong

Publication type:

Article

L‐type amino acid transporter 1 inhibitor JPH203 prevents the growth of cabazitaxel‐resistant prostate cancer by inhibiting cyclin‐dependent kinase activity.

Published in:

Cancer Science, 2024, v. 115, n. 3, p. 937, doi. 10.1111/cas.16062

By:

Rii, Junryo;
Sakamoto, Shinichi;
Mizokami, Atsushi;
Xu, Minhui;
Fujimoto, Ayumi;
Saito, Shinpei;
Koike, Hidekazu;
Tamura, Takaaki;
Arai, Takayuki;
Yamada, Yasutaka;
Goto, Yusuke;
Sazuka, Tomokazu;
Imamura, Yusuke;
Suzuki, Kazuhiro;
Kanai, Yoshikatsu;
Anzai, Naohiko;
Ichikawa, Tomohiko

Publication type:

Article

Nivolumab receptor occupancy on effector regulatory T cells predicts clinical benefit.

Published in:

Cancer Science, 2024, v. 115, n. 3, p. 752, doi. 10.1111/cas.16061

By:

Hosonuma, Masahiro;
Hirasawa, Yuya;
Kuramasu, Atsuo;
Murayama, Masakazu;
Narikawa, Yoichiro;
Toyoda, Hitoshi;
Baba, Yuta;
Isobe, Junya;
Funayama, Eiji;
Tajima, Kohei;
Shida, Midori;
Hamada, Kazuyuki;
Tsurui, Toshiaki;
Ariizumi, Hirotsugu;
Ishiguro, Tomoyuki;
Suzuki, Risako;
Ohkuma, Ryotaro;
Kubota, Yutaro;
Horiike, Atsushi;
Sambe, Takehiko

Publication type:

Article

Immature stroma and high infiltration of CD15+ cells are predictive markers of poor prognosis in different subsets of patients with pancreatic cancer.

Published in:

Cancer Science, 2024, v. 115, n. 3, p. 1001, doi. 10.1111/cas.16060

By:

Yamada, Yutaka;
Yamamoto, Takeo;
Tsutsumi, Chikanori;
Matsumoto, Takashi;
Noguchi, Shoko;
Shimada, Yuki;
Nakata, Kohei;
Ohuchida, Kenoki;
Nakamura, Masafumi;
Oda, Yoshinao

Publication type:

Article

Therapeutic potential of SHCBP1 inhibitor AZD5582 in pancreatic cancer treatment.

Published in:

Cancer Science, 2024, v. 115, n. 3, p. 820, doi. 10.1111/cas.16059

By:

Ma, Zhijian;
Gu, Qianlin;
Dai, Yiwei;
Wang, Qiaoyan;
Shi, Wengui;
Jiao, Zuoyi

Publication type:

Article

Molecular and clinicopathological features of KIT/PDGFRAwild‐type gastrointestinal stromal tumors.

Published in:

Cancer Science, 2024, v. 115, n. 3, p. 894, doi. 10.1111/cas.16058

By:

Nishida, Toshirou;
Naito, Yoichi;
Takahashi, Tsuyoshi;
Saito, Takuro;
Hisamori, Shigeo;
Manaka, Dai;
Ogawa, Katsuhiro;
Hirota, Seiichi;
Ichikawa, Hitoshi

Publication type:

Article

RNA methylation in inflammatory bowel disease.

Published in:

Cancer Science, 2024, v. 115, n. 3, p. 723, doi. 10.1111/cas.16048

By:

Ozato, Yuki;
Hara, Tomoaki;
Meng, Sikun;
Sato, Hiromichi;
Tatekawa, Shotaro;
Uemura, Mamoru;
Yabumoto, Takeshi;
Uchida, Shizuka;
Ogawa, Kazuhiko;
Doki, Yuichiro;
Eguchi, Hidetoshi;
Ishii, Hideshi

Publication type:

Article

Treatment sequencing after failure to alectinib in patients with anaplastic lymphoma kinase‐positive non‐small‐cell lung cancer.

Published in:

Cancer Science, 2024, v. 115, n. 3, p. 926, doi. 10.1111/cas.16056

By:

Shimomura, Yuki;
Sawa, Kenji;
Imai, Takumi;
Ihara, Yasutaka;
Yoshida, Hisako;
Shintani, Ayumi

Publication type:

Article

Effectiveness of catch‐up and routine program of the 9‐valent vaccine on cervical cancer risk reduction in Japan.

Published in:

Cancer Science, 2024, v. 115, n. 3, p. 916, doi. 10.1111/cas.16055

By:

Yagi, Asami;
Nakagawa, Satoshi;
Ueda, Yutaka;
Oka, Emiko;
Ikeda, Sayaka;
Kakuda, Mamoru;
Kobayashi, Eiji;
Ito, Yuri;
Katayama, Kayoko;
Hirai, Kei;
Nakayama, Tomio;
Kimura, Tadashi

Publication type:

Article

Achaete‐scute family bHLH transcription factor 2 activation promotes hepatoblastoma progression.

Published in:

Cancer Science, 2024, v. 115, n. 3, p. 847, doi. 10.1111/cas.16051

By:

Kato, Yutaka;
Fukazawa, Takahiro;
Tanimoto, Keiji;
Kanawa, Masami;
Kojima, Masato;
Saeki, Isamu;
Kurihara, Sho;
Touge, Ryo;
Hirohashi, Nobuyuki;
Okada, Satoshi;
Hiyama, Eiso

Publication type:

Article

LINC00629, a HOXB4‐downregulated long noncoding RNA, inhibits glycolysis and ovarian cancer progression by destabilizing c‐Myc.

Published in:

Cancer Science, 2024, v. 115, n. 3, p. 804, doi. 10.1111/cas.16049

By:

Liu, Jia;
Zhu, Yuan;
Wang, Huan;
Han, Chuanchun;
Wang, Yongpeng;
Tang, Ranran

Publication type:

Article

Clinical outcome and molecular landscape of patients with ARID1A‐loss gastric cancer.

Published in:

Cancer Science, 2024, v. 115, n. 3, p. 905, doi. 10.1111/cas.16057

By:

Sun, Mengyao;
Gu, Yun;
Fang, Hanji;
Shao, Fei;
Lin, Chao;
Zhang, Heng;
Li, He;
He, Hongyong;
Li, Ruochen;
Wang, Jieti;
Liu, Hao;
Xu, Jiejie

Publication type:

Article

Japanese Society of Medical Oncology clinical guidelines: Molecular testing for colorectal cancer treatment, 5th edition.

Published in:

Cancer Science, 2024, v. 115, n. 3, p. 1014, doi. 10.1111/cas.16039

By:

Bando, Hideaki;
Yamaguchi, Kyoko;
Mitani, Seiichiro;
Sawada, Kentaro;
Mishima, Saori;
Komine, Keigo;
Okugawa, Yoshinaga;
Hosoda, Waki;
Ebi, Hiromichi

Publication type:

Article

miRNA levels are associated with body mass index in endometrial cancer and may have implications for therapy.

Published in:

Cancer Science, 2024, v. 115, n. 3, p. 883, doi. 10.1111/cas.15977

By:

Ravegnini, Gloria;
Gorini, Francesca;
Coada, Camelia Alexandra;
De Leo, Antonio;
de Biase, Dario;
Di Costanzo, Stella;
De Crescenzo, Eugenia;
Coschina, Emma;
Monesmith, Sarah;
Bernante, Paolo;
Garelli, Silvia;
Balsamo, Francesca;
Hrelia, Patrizia;
De Iaco, Pierandrea;
Angelini, Sabrina;
Perrone, Anna Myriam

Publication type:

Article

Issue Information.

Published in:: Cancer Science, 2024, v. 115, n. 3, p. 691, doi. 10.1111/cas.15859
Publication type:: Article

Works matching IS 13479032 AND DT 2024 AND VI 115 AND IP 3

In this issue: Volume 115, Issue 3, March 2024.

Progressive, multi‐organ, and multi‐layered nature of cancer cachexia.

Role of catecholamine synthases in the maintenance of cancer stem‐like cells in malignant peripheral nerve sheath tumors.

DEAD‐box helicase 1 inhibited CD8<sup>+</sup> T cell antitumor activity by inducing PD‐L1 expression in hepatocellular carcinoma.

Stiffness promotes cell migration, invasion, and invadopodia in nasopharyngeal carcinoma by regulating the WT‐CTTN level.

Altered tumor signature and T‐cell profile after chemotherapy reveal new therapeutic opportunities in high‐grade serous ovarian carcinoma.

Interleukin‐4 induced 1‐mediated resistance to an immune checkpoint inhibitor through suppression of CD8<sup>+</sup> T cell infiltration in melanoma.

Why Y matters? The implication of loss of Y chromosome in blood and cancer.

Genome‐wide loss‐of‐function genetic screen identifies INSIG2 as the vulnerability of hepatitis B virus‐integrated hepatoma cells.

Enhancer‐activated RET confers protection against oxidative stress to KMT2A‐rearranged acute myeloid leukemia.

IRG1 restrains M2 macrophage polarization and suppresses intrahepatic cholangiocarcinoma progression via the CCL18/STAT3 pathway.

Circular RNA circWNK1 inhibits the progression of gastric cancer via regulating the miR‐21‐3p/SMAD7 axis.

Ex vivo expansion of human hematopoietic stem cells and clinical applications.

Patient survey on cancer genomic medicine in Japan under the national health insurance system.

Anti‐angiogenesis in colorectal cancer therapy.

L‐type amino acid transporter 1 inhibitor JPH203 prevents the growth of cabazitaxel‐resistant prostate cancer by inhibiting cyclin‐dependent kinase activity.

Nivolumab receptor occupancy on effector regulatory T cells predicts clinical benefit.

Immature stroma and high infiltration of CD15<sup>+</sup> cells are predictive markers of poor prognosis in different subsets of patients with pancreatic cancer.

Therapeutic potential of SHCBP1 inhibitor AZD5582 in pancreatic cancer treatment.

Molecular and clinicopathological features of KIT/PDGFRAwild‐type gastrointestinal stromal tumors.

RNA methylation in inflammatory bowel disease.

Treatment sequencing after failure to alectinib in patients with anaplastic lymphoma kinase‐positive non‐small‐cell lung cancer.

Effectiveness of catch‐up and routine program of the 9‐valent vaccine on cervical cancer risk reduction in Japan.

Achaete‐scute family bHLH transcription factor 2 activation promotes hepatoblastoma progression.

LINC00629, a HOXB4‐downregulated long noncoding RNA, inhibits glycolysis and ovarian cancer progression by destabilizing c‐Myc.

Clinical outcome and molecular landscape of patients with ARID1A‐loss gastric cancer.

Japanese Society of Medical Oncology clinical guidelines: Molecular testing for colorectal cancer treatment, 5th edition.

miRNA levels are associated with body mass index in endometrial cancer and may have implications for therapy.

Issue Information.